Summary of Study ST002200
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001403. The data can be accessed directly via it's Project DOI: 10.21228/M8C99T This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002200 |
Study Title | Human Trisome Project Plasma Metabolomics v1 |
Study Summary | Analysis of metabolite relative abundance in blood plasma from 316 individuals with trisomy 21 (T21, Down syndrome) and 103 euploid controls. This dataset is part of the Human Trisome Project run by the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus. http://www.trisome.org/ |
Institute | University of Colorado Denver |
Laboratory | PIs - Joaquin Espinosa and Angelo D'Alessandro |
Last Name | Haines |
First Name | Julie |
Address | 12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA |
julie.haines@cuanschutz.edu | |
Phone | 3037243339 |
Submit Date | 2022-06-15 |
Num Groups | 2 |
Total Subjects | 419 |
Raw Data Available | Yes |
Raw Data File Type(s) | raw(Thermo) |
Analysis Type Detail | LC-MS |
Release Date | 2023-06-15 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001403 |
Project DOI: | doi: 10.21228/M8C99T |
Project Title: | Human Trisome Project Plasma Metabolomics v1 |
Project Summary: | Analysis of metabolite relative abundance in blood plasma from 316 individuals with trisomy 21 (T21, Down syndrome) and 103 euploid controls. This dataset focuses on hydrophilic metabolites and oxylipins and is part of the Human Trisome Project (HTP, http://www.trisome.org/) run by the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus. This data is generated from samples matched at the blood draw to multiple omics datasets including proteomics, cytokine profiling, RNA-seq, and mass cytometry. The HTP is an in-depth study of people with Down syndrome using the latest technologies in precision medicine. The goal of the HTP is to enable advanced therapeutic approaches to enhance the quality of life and extend the lifespan of those with trisomy 21 through the study of the co-occurring conditions of Down syndrome. The HTP leverages a multidisciplinary team of biomedical researchers, clinicians and data scientists located across multiple departments, divisions, institutes and centers at the University of Colorado who work together toward a single goal: to decipher why people with trisomy 21 have a different disease spectrum, being predisposed to some medical conditions while being protected from others. The HTP Biobank provides de-identified samples and clinical information to collaborators that are necessary for investigations that advance our understanding of several co-occurring medical conditions in Down syndrome. Studies using samples and data from the HTP Biobank are enabling the development of novel diagnostics and therapeutic approaches, serving not only individuals with Down syndrome, but also the billions worldwide affected by conditions that commonly co-occur in Down syndrome. This collaborative and multi-disciplinary model allows for one of the largest and most comprehensive studies of individuals with Down syndrome to date, including extensive characterization at the clinical, physiological, cellular and molecular levels. |
Institute: | University of Colorado Denver |
Laboratory: | PIs - Joaquin Espinosa and Angelo D'Alessandro |
Last Name: | Haines |
First Name: | Julie |
Address: | 12801 E 17th Ave, Room 1303, Aurora, Colorado, 80045, USA |
Email: | julie.haines@cuanschutz.edu |
Phone: | 3037243339 |
Subject:
Subject ID: | SU002286 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Group |
---|---|---|
SA210738 | H-324 | D21 |
SA210739 | H-325 | D21 |
SA210740 | H-323 | D21 |
SA210741 | H-322 | D21 |
SA210742 | H-321 | D21 |
SA210743 | H-326 | D21 |
SA210744 | H-327 | D21 |
SA210745 | H-339 | D21 |
SA210746 | H-330 | D21 |
SA210747 | H-329 | D21 |
SA210748 | H-328 | D21 |
SA210749 | H-320 | D21 |
SA210750 | H-315 | D21 |
SA210751 | H-307 | D21 |
SA210752 | H-309 | D21 |
SA210753 | H-302 | D21 |
SA210754 | H-301 | D21 |
SA210755 | H-300 | D21 |
SA210756 | H-310 | D21 |
SA210757 | H-311 | D21 |
SA210758 | H-340 | D21 |
SA210759 | H-314 | D21 |
SA210760 | H-313 | D21 |
SA210761 | H-312 | D21 |
SA210762 | H-316 | D21 |
SA210763 | H-342 | D21 |
SA210764 | H-371 | D21 |
SA210765 | H-374 | D21 |
SA210766 | H-370 | D21 |
SA210767 | H-369 | D21 |
SA210768 | H-367 | D21 |
SA210769 | H-388 | D21 |
SA210770 | H-389 | D21 |
SA210771 | H-010 | D21 |
SA210772 | H-419 | D21 |
SA210773 | H-398 | D21 |
SA210774 | H-392 | D21 |
SA210775 | H-365 | D21 |
SA210776 | H-357 | D21 |
SA210777 | H-347 | D21 |
SA210778 | H-348 | D21 |
SA210779 | H-346 | D21 |
SA210780 | H-343 | D21 |
SA210781 | H-299 | D21 |
SA210782 | H-349 | D21 |
SA210783 | H-351 | D21 |
SA210784 | H-355 | D21 |
SA210785 | H-354 | D21 |
SA210786 | H-353 | D21 |
SA210787 | H-352 | D21 |
SA210788 | H-341 | D21 |
SA210789 | H-356 | D21 |
SA210790 | H-080 | D21 |
SA210791 | H-081 | D21 |
SA210792 | H-077 | D21 |
SA210793 | H-076 | D21 |
SA210794 | H-069 | D21 |
SA210795 | H-082 | D21 |
SA210796 | H-084 | D21 |
SA210797 | H-091 | D21 |
SA210798 | H-089 | D21 |
SA210799 | H-088 | D21 |
SA210800 | H-085 | D21 |
SA210801 | H-066 | D21 |
SA210802 | H-065 | D21 |
SA210803 | H-037 | D21 |
SA210804 | H-043 | D21 |
SA210805 | H-036 | D21 |
SA210806 | H-298 | D21 |
SA210807 | H-034 | D21 |
SA210808 | H-051 | D21 |
SA210809 | H-054 | D21 |
SA210810 | H-063 | D21 |
SA210811 | H-059 | D21 |
SA210812 | H-058 | D21 |
SA210813 | H-056 | D21 |
SA210814 | H-092 | D21 |
SA210815 | H-057 | D21 |
SA210816 | H-244 | D21 |
SA210817 | H-256 | D21 |
SA210818 | H-243 | D21 |
SA210819 | H-240 | D21 |
SA210820 | H-231 | D21 |
SA210821 | H-261 | D21 |
SA210822 | H-281 | D21 |
SA210823 | H-294 | D21 |
SA210824 | H-292 | D21 |
SA210825 | H-101 | D21 |
SA210826 | H-290 | D21 |
SA210827 | H-283 | D21 |
SA210828 | H-224 | D21 |
SA210829 | H-264 | D21 |
SA210830 | H-137 | D21 |
SA210831 | H-162 | D21 |
SA210832 | H-206 | D21 |
SA210833 | H-152 | D21 |
SA210834 | H-154 | D21 |
SA210835 | H-170 | D21 |
SA210836 | H-169 | D21 |
SA210837 | H-183 | D21 |
Collection:
Collection ID: | CO002279 |
Collection Summary: | All study participants were enrolled in the Crnic Institute Human Trisome Project (HTP) under a study protocol approved by the Colorado Multiple Institutional Review Board (NCT02864108, see also www.trisome.org). Written informed consent was obtained from all study participants or their legal guardians. Data were generated from deidentified biospecimens and linked to demographics and clinical metadata for analysis. Peripheral blood samples were collected into BD Vacutainer K2 EDTA tubes (BD, Cat # 366643) and processed within 2 hrs of blood draw by centrifugation at 700 x g for 15 min to separate plasma, buffy coat (white blood cells, WBCs), and red blood cells (RBCs) which were aliquoted, flash-frozen, and stored at -80°C. Subsequent processing was carried out as described below, with aliquots selected to minimize freeze/thaw cycles. |
Sample Type: | Blood (plasma) |
Treatment:
Treatment ID: | TR002298 |
Treatment Summary: | n/a |
Sample Preparation:
Sampleprep ID: | SP002292 |
Sampleprep Summary: | Metabolite extraction: Samples were thawed on ice and 20 μL of sample was diluted in 480 μL of LC-MS grade cold methanol/acetonitrile/water (5:3:2). Samples were incubated at 4°C for 30 min with vigorous vortexing. Supernatants were clarified by centrifugation (10 min, 18,213 g, 4C) then 50 uL aliquots were transferred to autosampler vials. Lipid extraction: Samples were thawed on ice and 10 uL of sample was diluted in 90 uL of LC-MS grade cold methanol. Samples were briefly vortexed to mix then incubated for 30 min at -20C. Supernatants were clarified by centrifugation (10 min, 18,213 g, 4C) then 25 uL aliquots were transferred to autosampler vials and diluted with 25 uL of 10 mM ammonium acetate. |
Combined analysis:
Analysis ID | AN003600 | AN003601 | AN003602 | AN003603 |
---|---|---|---|---|
Analysis type | MS | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | Reversed phase | Reversed phase |
Chromatography system | Thermo Vanquish | Thermo Vanquish | Thermo Vanquish | Thermo Vanquish |
Column | Phenomenex Kinetex C18 (150 x 2.1mm,1.7um) | Phenomenex Kinetex C18 (150 x 2.1mm,1.7um) | Waters ACQUITY HSS T3 (150 x 2.1mm,1.8um) | Waters ACQUITY HSS T3 (150 x 2.1mm,1.8um) |
MS Type | ESI | ESI | ESI | ESI |
MS instrument type | Orbitrap | Orbitrap | Orbitrap | Orbitrap |
MS instrument name | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap | Thermo Q Exactive Orbitrap |
Ion Mode | NEGATIVE | POSITIVE | NEGATIVE | POSITIVE |
Units | peak area | peak area | peak area | peak area |
Chromatography:
Chromatography ID: | CH002660 |
Chromatography Summary: | 5 minute negative metabolites |
Methods Filename: | Merged_chromatography_methods_metabolites_and_lipids.docx |
Instrument Name: | Thermo Vanquish |
Column Name: | Phenomenex Kinetex C18 (150 x 2.1mm,1.7um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002661 |
Chromatography Summary: | 5 minute positive metabolites |
Methods Filename: | Merged_chromatography_methods_metabolites_and_lipids.docx |
Instrument Name: | Thermo Vanquish |
Column Name: | Phenomenex Kinetex C18 (150 x 2.1mm,1.7um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002662 |
Chromatography Summary: | 17 minute negative oxylipins |
Methods Filename: | Merged_chromatography_methods_metabolites_and_lipids.docx |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters ACQUITY HSS T3 (150 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002663 |
Chromatography Summary: | 15 minute positive metabolites |
Methods Filename: | Merged_chromatography_methods_metabolites_and_lipids.docx |
Instrument Name: | Thermo Vanquish |
Column Name: | Waters ACQUITY HSS T3 (150 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS003355 |
Analysis ID: | AN003600 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Resolution 70,000, scan range 65-900 m/z, maximum injection time 200 ms, microscans 2, automatic gain control (AGC) 3 x 10^6 ions, source voltage 4.0 kV, capillary temperature 320 C, and sheath gas 45, auxiliary gas 15, and sweep gas 0 (all nitrogen). Data converted to mzXML using RawConverter. Metabolites were annotated and integrated using Maven in conjunction with the KEGG database. |
Ion Mode: | NEGATIVE |
MS ID: | MS003356 |
Analysis ID: | AN003601 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Resolution 70,000, scan range 65-900 m/z, maximum injection time 200 ms, microscans 2, automatic gain control (AGC) 3 x 10^6 ions, source voltage 4.0 kV, capillary temperature 320 C, and sheath gas 45, auxiliary gas 15, and sweep gas 0 (all nitrogen). Data converted to mzXML using RawConverter. Metabolites were annotated and integrated using Maven in conjunction with the KEGG database. |
Ion Mode: | POSITIVE |
MS ID: | MS003357 |
Analysis ID: | AN003602 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Resolution 70,000, scan range 150-1500 m/z, maximum injection time 200 ms, microscans 2, automatic gain control (AGC) 3 x 10^6 ions, source voltage 4.0 kV, capillary temperature 320 C, and sheath gas 45, auxiliary gas 15, and sweep gas 0 (all nitrogen). Data converted to mzXML using RawConverter. Metabolites were annotated and integrated using Maven in conjunction with the KEGG database. |
Ion Mode: | NEGATIVE |
MS ID: | MS003358 |
Analysis ID: | AN003603 |
Instrument Name: | Thermo Q Exactive Orbitrap |
Instrument Type: | Orbitrap |
MS Type: | ESI |
MS Comments: | Resolution 70,000, scan range 150-1500 m/z, maximum injection time 200 ms, microscans 2, automatic gain control (AGC) 3 x 10^6 ions, source voltage 4.0 kV, capillary temperature 320 C, and sheath gas 45, auxiliary gas 15, and sweep gas 0 (all nitrogen). Data converted to mzXML using RawConverter. Metabolites were annotated and integrated using Maven in conjunction with the KEGG database. |
Ion Mode: | POSITIVE |